|Neurology | Clinical Neurosciences | School of Medicine | University of Utah Health Care|
The University of Utah
Center for Alzheimer's Care,
Imaging and Research (CACIR)
Memory Study Line
Tel (801) 587-7888
Cognitive Disorders Clinic
Tel (801) 585-7575
Fax (801) 585-2746
Imaging & Neurosciences Center
729 Arapeen Drive
Salt Lake City, UT 84108
Follow us on Facebook
Follow us on Twitter
Edward Zamrini, M.D.
Professor of Neurology
Improving Alzheimer’s Treatments
As Director of Clinical Trials at the University of Utah Center for Alzheimer's Care, Imaging and Research (CACIR), Dr. Zamrini leads the way in testing promising new treatments for Alzheimer's disease and related disorders. He has gained a broad expertise through over 20 years of clinical experience with Alzheimer's, and as an investigator in more than 50 clinical studies.
Detecting Alzheimer's before symptoms appear is one of Dr. Zamrini's primary goals. "Research into early diagnosis and therapeutic intervention can help us to lessen the impact of the disease and, ultimately, delay or prevent it," he says. He urges people not to wait if they suspect that something is awry, because early diagnosis can enable application of more effective therapies and management.
In 2006, Dr. Zamrini joined the University of Utah Department of Neurology, where he is also Director of Clinical Trials at the Center for Alzheimer's Care, Imaging and Research (CACIR). He is an active member of the Brain Institute at the University of Utah.
Dr. Zamrini received his M.D. from the University of Beirut in Lebanon. After his internship at the Lutheran Medical Center in Brooklyn, he completed his residency at New York's North Shore University Hospital, where he was chief resident of Neurology. Dr. Zamrini completed fellowships in Epilepsy and in Neurogeriatrics and Behavioral Neurology at the Medical College of Georgia in Augusta, before going on to direct the Geriatric Neuropsychiatry Program at Augusta's VA Medical Center.
Prior to joining the University of Utah in 2006, Dr. Zamrini served as Director of the Clinical and Information Transfer Cores of the NIH-funded Alzheimer's Disease Research Center at the University of Alabama at Birmingham.
Dr. Zamrini is an affiliate of the Alzheimer's Disease Cooperative Study (ADCS), a national research consortium funded by the NIA to conduct multi-center studies. He is a member of the American Academy of Neurology, American College of Physicians, and New York Academy of Sciences. He is actively involved in the Salt Lake community, and participates in educational programs offered by the Alzheimer's Association, AARP, and the Osher Lifelong Learning Institute and Brain Institute at the University of Utah.
Dr. Zamrini's research has focused primarily on clinical drug trials, imaging studies using PET and MEG, and the clinical features and pathophysiology of Alzheimer's and related neurodegenerative disorders. Dr. Zamrini and his colleagues are currently studying novel compounds to aid in early detection and measuring the extent of disease. He is also involved in numerous ongoing clinical drug trials, which explore new therapies in various stages of the disease.
Click here to view Dr. Zamrini's NIH Biosketch.
View a more complete list of Dr. Zamrini's publications here, at PubMed.